Genentech

KADCYLA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / KADCYLA – J9354

Manufacturer:

Genentech

Name:

KADCYLA

HCPCS Code Descriptor:

Injection, ado-trastuzumab emtansine, 1 mg

Category:

J Code

HCPCS:

J9354

NDC(s):

50242-0087-01, 50242-0088-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

KADCYLA is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9354 is aligned to the drug KADCYLA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/14

HCPCS Effective Date:

1/1/14

HCPCS Short Description:

Inj, ado-trastuzumab emt 1mg

Billing and Coding Guide:

https://www.genentech-access.com/content/dam/gene/accesssolutions/pdfs/coding/KADCYLA-Billing-Coding-for-Breast-Cancer.pdf

Patient Assistance:

https://www.gene.com/patients/patient-foundation

KADCYLA - J9354